🔎 Trials Near Me

Beranda › Tekanan Darah Tinggi › Alabama

Uji klinis Tekanan Darah Tinggi di Alabama

15 studi untuk Tekanan Darah Tinggi mencari peserta di lokasi di Alabama.

Kota di Alabama

Teks studi resmi (Bahasa Inggris)

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

  • Retension Clinical Site, Alexander City
  • Retension Clinical Site, Birmingham
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07142356

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Heart Center Research, LLC, Huntsville
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Pinnacle Research Group, LLC, Anniston
  • Eastern Shore Research Group, Fairhope
  • Lakeview Clinical Research, Guntersville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07064473

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Pinnacle Research Group, LLC, Anniston
  • Central Research Associates, Birmingham
  • Cahaba Research - Pelham, Pelham
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07794579

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

  • Cardiology, PC, Birmingham
Menerima peserta
Usia 22 hingga 75 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06559891

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Birmingham
  • Clinical Trial Site, Birmingham
  • Clinical Trial Site, Fairhope
  • dan 4 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07181109

Therapeutic Mechanisms of Epidural Spinal Cord Stimulation

  • University of Alabama at Birmingham, Birmingham
Menerima peserta
Usia 18 hingga 89 · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT05556902

A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia

  • G and L Research LLC, Foley
  • The Center for Clinical Trials, Saraland
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT07610278

Early Time-Restricted Eating in Older Adults With Hypertension

  • University of Alabama at Birmingham, Birmingham
Menerima peserta
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT07135505

Arterial Stiffness and Blood Pressure

  • Birmingham VA Medical Center, Birmingham, AL, Birmingham
Menerima peserta
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06495710

PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis

  • University of Alabama at Birmingham, Birmingham
Menerima pesertaFase 2/3Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT04971720

CARBON: UAB Cardiovascular Research Biobank

  • University of Alabama at Birmingham, Birmingham
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT05067231

Inspire HER: Inspiring the Heart and Emotions for Radical Health

  • University of Alabama at Birmingham, Birmingham
Menerima peserta
Usia 30 hingga 79 · Wanita · Diperbarui 29 Des 2025 · NCT06966258

Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure

  • University of Alabama at Birmingham, Birmingham
Menerima peserta
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 3 Sep 2025 · NCT06962488

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.